Mitsubishi UFJ Asset Management
MRVI icon

Mitsubishi UFJ Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Sell
53,067
-11,793
-18% -$50.9K ﹤0.01% 947
2026
Q1 		$184K Sell
64,860
-1,603
-2% -$5.43K ﹤0.01% 992
2025
Q4 		$226K Buy
+66,463
New +$224K ﹤0.01% 1000
2025
Q2 		– Sell
-57,311
Closed -$127K – 1635
2025
Q1 		$127K Buy
57,311
+4,803
+9% +$19K ﹤0.01% 1003
2024
Q4 		$298K Buy
52,508
+28,480
+119% +$183K ﹤0.01% 930
2024
Q3 		$200K Sell
24,028
-2,266
-9% -$19.6K ﹤0.01% 965
2024
Q2 		$188K Sell
26,294
-21,373
-45% -$185K ﹤0.01% 965
2024
Q1 		$413K Sell
47,667
-2,183
-4% -$14.8K ﹤0.01% 892
2023
Q4 		$316K Buy
49,850
+29,231
+142% +$189K ﹤0.01% 969
2023
Q3 		$206K Buy
20,619
+1,170
+6% +$12.8K ﹤0.01% 1020
2023
Q2 		$242K Buy
19,449
+815
+4% +$11K ﹤0.01% 1020
2023
Q1 		$261K Buy
18,634
+1,264
+7% +$18.2K ﹤0.01% 994
2022
Q4 		$238K Buy
17,370
+9,765
+128% +$154K ﹤0.01% 1005
2022
Q3 		$194K Hold
7,605
– – ﹤0.01% 1026
2022
Q2 		$216K Sell
7,605
-861
-10% -$27.3K ﹤0.01% 1037
2022
Q1 		$299K Buy
8,466
+914
+12% +$30.6K ﹤0.01% 1000
2021
Q4 		$300K Buy
7,552
+1,761
+30% +$71.3K ﹤0.01% 1010
2021
Q3 		$284K Sell
5,791
-50
-0.9% -$2.44K ﹤0.01% 1016
2021
Q2 		$244K Buy
+5,841
New +$226K ﹤0.01% 1069

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management's MRVI Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Maravai LifeSciences (MRVI) stake by 18% in Q2 2026, selling an estimated $50.9K and leaving 53,067 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Mitsubishi UFJ Asset Management first reported a position in MRVI in Q2 2021 and has held it in 19 quarters since. The position peaked at $413K in Q1 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 53,067 shares of Maravai LifeSciences worth $331K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 11,793 Maravai LifeSciences shares in Q2 2026, an estimated $50.9K.
  • Maravai LifeSciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #947 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 19 quarters since.
  • Mitsubishi UFJ Asset Management's Maravai LifeSciences position peaked at $413K in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.